Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
July 29, 2020: Comprehensive Cancer Care Centers and Integrated Delivery Systems Update: COVID-19 Recovery, the Road Ahead
COVID-19
Al B. Benson III, MD
Professor, Medicine
Northwestern University Feinberg School of Medicine
Robert H. Lurie Comprehensive Cancer Center
Chicago, IL
Howard “Skip” Burris, III, MD, FACP, FASCO
President & Chief Medical Officer
Sarah Cannon
Christian Downs, MHA, JD
Executive Director, Association of Community Cancer Centers
Timothy Kubal, MBA, MD
Senior Medical Director
Moffitt Cancer Center - Tampa
Julian Schink, MD
CMO
Cancer Treatment Centers of America
Burt Zweigenhaft, PhD, D.Litt
Editor-in-Chief,
VBCC
;
Executive Vice President, FFF Enterprises;
Executive Director and Co-Founder, Association for Value-Based Cancer Care
From shuttered laboratory experiments and interrupted clinical trial enrollments to a “shadow curve” of delayed cancer diagnoses, comprehensive cancer centers and integrated delivery networks (IDNs) across the country continue to grapple with the fallout from COVID-19.
Related Articles
mRNA COVID-19 Vaccine Appears Safe and Effective in Patients with Cancer Receiving Active Treatment
By
Chase Doyle
COVID-19
February 2022, Vol 13, No 1 Online Only
Read Article
Multicancer Detection: The Need for Clinical Guidance
By
Jaffer A. Ajani, MD
;
Al B. Benson III, MD
;
Mary B. Daly, MD, PhD, FACP
;
David S. Ettinger, MD
;
Maria M. Ho, PhD
Clinical Guidelines
October 2021, Vol 12, No 5
Read Article
Current and Future Effects of the COVID-19 Pandemic on Cancer Care
By
Phoebe Starr
COVID-19
June 2021, Vol 12, No 3
Read Article
Later Diagnoses, Worse Outcomes in Patients with Lung Cancer During COVID-19 May Last
By
Walter Alexander
COVID-19
,
Lung Cancer
April 2021, Vol 12, No 2
Read Article
Patients with Lung Cancer Distressed About Impact of COVID-19 on Access to Care
By
Walter Alexander
COVID-19
April 2021, Vol 12, No 2
Read Article
AVBCC Celebrates World Cancer Day
By
Burt Zweigenhaft, PhD, D.Litt
Videos
Read Article
Managing Cholangiocarcinoma in the Setting of COVID-19: Unique Challenges and Opportunities
By
Ghassan K. Abou-Alfa, MD, MBA
;
Bruce Lin, MD
;
Farshid Dayyani, MD, PhD
;
Richard Kim, MD
;
Rachna T. Shroff, MD, MS
;
Melinda Bachini
;
Milind M. Javle, MD
Cholangiocarcinoma
,
COVID-19
December 2020, Special Issue: Managing CCA in the Setting of COVID-19
Read Article
COVID-Related Death Rate Tripled in Patients with Cancer versus the General Population
By
Phoebe Starr
AACR COVID-19 Highlights
,
COVID-19
October 2020, Vol 11, No 5
Read Article
Managed Care, Oncology, and Telehealth in the Era of COVID-19
COVID-19
August 2020, Vol 11, Special Issue: Payers' Perspectives in Oncology
Read Article
Top Trending Articles
1.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
2.
HOPA Highlights: What's New in 2025?
3.
Peer Navigation Intervention Aims to Boost Childhood Cancer Clinical Trial Participation
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma